On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

CHI Health

InstitutionResearch output, impact & collaborations

CHI Health is a institution indexed in ScholarIQ from OpenAlex.

What is known about CHI Health?

ScholarIQrecord summary

CHI Health is a research organisation in Omaha, US. OpenAlex records 1,378 works and 23,406 citations for it. 544 researchers list it as their most recent affiliation.

How many works does CHI Health have?

ScholarIQindexed works

CHI Health has 1,378 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does CHI Health have?

ScholarIQcitation count

CHI Health has 23,406 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at CHI Health?

ScholarIQresearcher count

CHI Health has 544 researchers in the ScholarIQ index.

What is the average h-index at CHI Health?

ScholarIQavg h-index

CHI Health has an average h-index of 56 in OpenAlex.

What is the ROR of CHI Health?

ScholarIQror

The ROR for CHI Health is on the source record.

What is the OpenAlex record for CHI Health?

ScholarIQopenalex

The OpenAlex for CHI Health is on the source record.

What is the Wikidata of CHI Health?

ScholarIQwikidata

The Wikidata for CHI Health is on the source record.

Who are the most-cited researchers behind CHI Health?

ScholarIQtop researchers by citations
1
Yasuhiro Shimada · Colorectal Cancer Treatments and Studies
523 works22,984 citations
2
Akira Hishida · Chronic Kidney Disease and Diabetes
442 works18,253 citations

What are the most-cited papers on CHI Health?

ScholarIQmost cited works
Revised Equations for Estimated GFR From Serum Creatinine in Japan
Seiichi Matsuo, Enyu Imai, Masaru Horio, Yoshinari Yasuda, Kimio Tomita, Kosaku Nitta, Kunihiro Yamagata, Yasuhiko Tomino, Hitoshi Yokoyama, Akira Hishida
American Journal of Kidney Diseases. 20096,485 Citations
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
Japanese Society for Cancer of the Colon and Rectum, Toshiaki Watanabe, Kei Muro, Yoichi Ajioka, Yojiro Hashiguchi, Yoshinori Ito, Yutaka Saito, Tetsuya Hamaguchi, Hideyuki Ishida, Megumi Ishiguro, Soichiro Ishihara, Yukihide Kanemitsu, Hiroshi Kawano, Yusuke Kinugasa, Norihiro Kokudo, Keiko Murofushi, Takako Eguchi Nakajima, Shiro Oka, Yoshiharu Sakai, Akihito Tsuji, Keisuke Uehara, Hideki Ueno, Kentaro Yamazaki, Masahiro Yoshida, Takayuki Yoshino, Narikazu Boku, Takahiro Fujimori, Michio Itabashi, Nobuo Koinuma, Takayuki Morita, Genichi Nishimura, Yuh Sakata, Yasuhiro Shimada, Keiichi Takahashi, Shinji Tanaka, Osamu Tsuruta, Toshiharu Yamaguchi, Naohiko YAMAGUCHI, Toshiaki Tanaka, Kenjiro Kotake, Kenichi Sugihara
International Journal of Clinical Oncology. 20172,494 CitationsOPEN ACCESS
Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
H. Wilke, Kei Muro, Eric Van Cutsem, Sang-Cheul Oh, G. Bodoky, Yasuhiro Shimada, Shuichi Hironaka, Naotoshi Sugimoto, Oleg Lipatov, Tae‐You Kim, David Cunningham, Philippe Rougier, Yoshito Komatsu, Jaffer A. Ajani, Michael Emig, Roberto Carlesi, David Ferry, Kumari Chandrawansa, Jonathan D. Schwartz, Atsushi Ohtsu
The Lancet Oncology. 20142,486 Citations
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
Yojiro Hashiguchi, Kei Muro, Yutaka Saitō, Yoshinori Ito, Yoichi Ajioka, Tetsuya Hamaguchi, Kiyoshi Hasegawa, Kinichi Hotta, Hideyuki Ishida, Megumi Ishiguro, Soichiro Ishihara, Yukihide Kanemitsu, Yusuke Kinugasa, Keiko Nemoto Murofushi, Takako Eguchi Nakajima, Shiro Oka, Toshiaki Tanaka, Hiroya Taniguchi, Akihito Tsuji, Keisuke Uehara, Hideki Ueno, Takeharu Yamanaka, Kentaro Yamazaki, Masahiro Yoshida, Takayuki Yoshino, Michio Itabashi, Kentaro Sakamaki, Keiji Sano, Yasuhiro Shimada, Shinji Tanaka, Hiroyuki Uetake, Shigeki Yamaguchi, Naohiko YAMAGUCHI, Hirotoshi Kobayashi, Keiji Matsuda, Kenjiro Kotake, Kenichi Sugihara, Japanese Society for Cancer of the Colon and Rectum
International Journal of Clinical Oncology. 20191,983 CitationsOPEN ACCESS
Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study
James C. Yao, Nicola Fazio, Simron Singh, Roberto Buzzoni, Carlo Carnaghi, Edward M. Wolin, Jiří Tomášek, Markus Raderer, Harald Lahner, Maurizio Voi, Lida Pacaud, Nicolas Rouyrre, Carolin Sachs, Juan W. Valle, Gianfranco Delle Fave, Eric Van Cutsem, Margot Tesselaar, Yasuhiro Shimada, Do‐Youn Oh, Jonathan Strosberg, Matthew H. Kulke, Marianne Pavel
The Lancet. 20151,272 Citations

How much of the research on CHI Health is open access?

ScholarIQopen access share
33%OPEN ACCESS
Gold
0%
Green
8%
Hybrid
17%
Bronze
8%
Closed
67%

Related on ScholarIQ

470M+ articles · 14-day free trial